Channels

Wed, Oct 16 8:14pm

0 Best Performing 2019

These are the BEST stocks this year in terms of YTD percentage gain. "The trend is your friend."

See also worst performing stocks year to date.

Noteworthy events last week, this week and next week.

Sun, Oct 6 - Sat, Oct 12

Study the past if you would define the future.
Confucius

Nothing to see here.

Sun, Oct 13 - Sat, Oct 19

The pessimist sees difficulty in every opportunity. The optimist sees opportunity in every difficulty.
Winston Churchill

All Time Highs 52 Week Highs

Sun, Oct 20 - Sat, Oct 26

The best way to predict the future is to create it.
Abraham Lincoln

Earnings Annoucements
071


SHOP $323.64 22.44 (6.48%)
Shopify
NYSE: SHOP $40 Billion Large-Cap. Software industry. 5 Year Return 1,160%. 1 Year Return 136%. 2019 YTD Return 135%. Earnings in 12 days on Tue, Oct 29. (Use the Earnings tab below to add this date to your calendar.)

SHOP Profile

Market Cap 40 Billion
SHOP Description

Shopify offers an e-commerce platform primarily to small and midsize businesses. The firm has two segments: subscription solutions (43% of fiscal 2018 revenue) and merchant solutions (57% of fiscal 2018 revenue). The subscription solutions segment allows Shopify merchants to conduct e-commerce on a variety of platforms, including the company's website, physical stores, pop-up stores, kiosks, social networks (Facebook), and Amazon. Merchant solutions are add-on products for the platform that facilitate e-commerce and include Shopify Pay, Shopify Shipping, and Shopify Capital.


Visit Website

SHOP Earnings

EPS -0.26 P/E Ratio 0.00
Previous Thu, Aug 1, 2019
Latest Tue, Oct 29, 2019 (In 13 days)

SHOP Dividend

Yield --
Ex-Date --
Pay Date --
History --

SHOP Charts

$117.64
1 Year
$409.61
Dec 24, 2018
Aug 27, 2019


SNAP $13.67 0.42 (2.98%)
Snap
NYSE: SNAP $22 Billion Large-Cap. Online Media industry. 5 Year Return 20%. 1 Year Return 94%. 2019 YTD Return 136%. Earnings in 5 days on Tue, Oct 22. (Use the Earnings tab below to add this date to your calendar.)

SNAP Profile

Market Cap 22 Billion
SNAP Description

Snap, which refers to itself as a camera company, has one of the most popular social networking apps, Snapchat, in developed regions such as North America and Europe. The firm has approximately 158 million daily active users. Snap generates nearly all of its revenue from advertising with 88% coming from the U.S. The firm is headquartered in Venice, California.


Visit Website

SNAP Earnings

EPS -0.19 P/E Ratio 0.00
Previous Tue, Jul 23, 2019
Latest Tue, Oct 22, 2019 (In 6 days)

SNAP Dividend

Yield --
Ex-Date --
Pay Date --
History --

SNAP Charts

$4.82
1 Year
$18.36
Dec 21, 2018
Jul 26, 2019


ROKU $132.50 0.32 (0.24%)
Roku
NASDAQ: ROKU $17 Billion Large-Cap. Communication Services industry. 5 Year Return 464%. 1 Year Return 118%. 2019 YTD Return 307%. Earnings in 20 days on Wed, Nov 6. (Use the Earnings tab below to add this date to your calendar.)

ROKU Profile

Market Cap 17 Billion
ROKU Description

Roku Inc operates TV streaming platform in the United States. Its TV streaming platform allows users to discover and access a variety of movies and TV episodes, as well as live sports, music, news, and others. The operating segments of the company are Player and Platform. It derives key revenue from the Player segment which consists of net sales of streaming media players and accessories through retailers and distributors, as well as directly to customers through the company's website. Platform segment consists of fees received from advertisers and content publishers, and from licensing the company's technology and proprietary operating system with TV brands and service operators.


Visit Website

ROKU Earnings

EPS -0.08 P/E Ratio 0.00
Previous Wed, Aug 7, 2019
Latest Wed, Nov 6, 2019 (In 21 days)

ROKU Dividend

Yield --
Ex-Date --
Pay Date --
History --

ROKU Charts

$26.30
1 Year
$176.55
Dec 24, 2018
Sep 9, 2019


SE $28.09 0.19 (0.67%)
Sea Ltd
NYSE: SE $14 Billion Large-Cap. Software industry. 5 Year Return 26%. 1 Year Return 105%. 2019 YTD Return 154%.

SE Profile

Market Cap 14 Billion
SE Description

Sea Ltd is an internet company. It has developed an integrated platform consisting of digital entertainment, e-commerce, and digital financial services. The company operates through three segments namely Digital entertainment, E-commerce, and Digital financial services. Digital entertainment segment offers users easy access to exclusive content online through Garena digital entertainment platform. E-commerce segment operates a third-party marketplace through the Shopee mobile app and websites that connect buyers and sellers. Digital financial services segment provides a variety of financial services to including e-wallet and payment services through the AirPay mobile app and AirPay counter applications on mobile phones or computers. Most of the company's revenue comes from Thailand.


Visit Website

SE Earnings

EPS -0.49 P/E Ratio 0.00
Previous Tue, Aug 20, 2019
Latest Tue, Nov 19, 2019 (In 34 days)

SE Dividend

Yield --
Ex-Date --
Pay Date --
History --

SE Charts

$10.52
1 Year
$38.00
Dec 21, 2018
Jul 29, 2019


CVNA $76.55 1.28 (1.64%)
Carvana
NYSE: CVNA $12 Billion Large-Cap. Retail Discretionary industry. 5 Year Return 590%. 1 Year Return 71%. 2019 YTD Return 137%. Earnings in 20 days on Wed, Nov 6. (Use the Earnings tab below to add this date to your calendar.)

CVNA Profile

Market Cap 12 Billion
CVNA Description

Carvana Co is an e-commerce platform for buying and selling used cars. The company derives revenue from used vehicle sales, wholesale vehicle sales and other sales and revenues, which includes commissions on VSCs, gains on the sales of automotive finance receivables, interest income received on finance receivables and delivery fee revenues.


Visit Website

CVNA Earnings

EPS -0.58 P/E Ratio 0.00
Previous Wed, Aug 7, 2019
Latest Wed, Nov 6, 2019 (In 21 days)

CVNA Dividend

Yield --
Ex-Date --
Pay Date --
History --

CVNA Charts

$28.44
1 Year
$85.07
Dec 21, 2018
Sep 9, 2019


COUP $140.31 14.38 (9.30%)
Coupa Software Inc
NASDAQ: COUP $9 Billion Mid-Cap. Software industry. 5 Year Return 146%. 1 Year Return 109%. 2019 YTD Return 125%.

COUP Profile

Market Cap 9 Billion
COUP Description

Coupa Software is a cloud-based, business spend management (BSM) platform that provides companies with more control and visibility into how they spend money. Since it was founded in 2006, Coupa has connected buyers with suppliers and helped buyers save money by improving procurement, expense management, and invoice processing. The company is headquartered in San Mateo, California, and went public in October 2016.


Visit Website

COUP Earnings

EPS -0.32 P/E Ratio 0.00
Previous Tue, Sep 3, 2019
Latest Mon, Dec 2, 2019 (In 47 days)

COUP Dividend

Yield --
Ex-Date --
Pay Date --
History --

COUP Charts

All Time High $159.97 set on Mon, Oct 14, 2019.
$52.01
1 Year
$159.97
Nov 20, 2018
Oct 14, 2019


NVCR $76.14 2.55 (3.24%)
NovoCure Ltd
NASDAQ: NVCR $8 Billion Mid-Cap. Medical Equipment & Devices industry. 5 Year Return 317%. 1 Year Return 68%. 2019 YTD Return 133%. Earnings in 14 days on Thu, Oct 31. (Use the Earnings tab below to add this date to your calendar.)

NVCR Profile

Market Cap 8 Billion
NVCR Description

NovoCure Ltd serves in the healthcare sector of United States. Its business involves commercial stage oncology operations involving therapies to cure critical tumors. Its key offering is the TTFields therapy, which is a low-toxicity anti-mitotic treatment that uses low-intensity, intermediate frequency, alternating electric fields to exert physical forces on molecules inside cancer cells, thereby leading to cancer cell death. NovoCure derives its major revenues in the United States, through the sale of TTFields delivery system, which includes a portable electric field generator, transducer arrays, rechargeable batteries, and accessories.


Visit Website

NVCR Earnings

EPS -0.01 P/E Ratio 0.00
Previous Thu, Jul 25, 2019
Latest Thu, Oct 31, 2019 (In 15 days)

NVCR Dividend

Yield --
Ex-Date --
Pay Date --
History --

NVCR Charts

$26.02
1 Year
$98.70
Nov 20, 2018
Aug 21, 2019


ACAD $39.90 0.26 (0.65%)
ACADIA Pharmaceuticals Inc
NASDAQ: ACAD $6 Billion Mid-Cap. Biotech & Pharma industry. 5 Year Return 53%. 1 Year Return 74%. 2019 YTD Return 140%. This is Uptrending. A good sign. Earnings in 19 days on Tue, Nov 5. (Use the Earnings tab below to add this date to your calendar.)

ACAD Profile

Market Cap 6 Billion
ACAD Description

Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.


Visit Website

ACAD Earnings

EPS -0.38 P/E Ratio 0.00
Previous Wed, Jul 31, 2019
Latest Tue, Nov 5, 2019 (In 20 days)

ACAD Dividend

Yield --
Ex-Date --
Pay Date --
History --

ACAD Charts

$14.01
1 Year
$44.85
Dec 24, 2018
Sep 16, 2019


ONCE $100.12 1.04 (1.05%)
Spark Therapeutics Inc
NASDAQ: ONCE $4 Billion Mid-Cap. Biotech & Pharma industry. 5 Year Return 100%. 1 Year Return 97%. 2019 YTD Return 156%. Earnings in 19 days on Tue, Nov 5. (Use the Earnings tab below to add this date to your calendar.)

ONCE Profile

Market Cap 4 Billion
ONCE Description

Spark Therapeutics Inc is a United States based company operating in the field of gene therapy. It is focused on debilitating genetic diseases by developing one-time, life-altering treatments. The company's product candidates are in the field of retina-directed gene therapies, liver-directed gene therapies, and central nervous system therapies. The entity's key product, LUXTURNA, is for the treatment of patients with viable retinal cells and confirmed biallelic RPE65 mutation-associated retinal dystrophy. It generates revenue primarily from the license and collaborative agreements.


Visit Website

ONCE Earnings

EPS -1.66 P/E Ratio 0.00
Previous Thu, Aug 8, 2019
Latest Tue, Nov 5, 2019 (In 20 days)

ONCE Dividend

Yield --
Ex-Date --
Pay Date --
History --

ONCE Charts

$34.53
1 Year
$114.20
Dec 26, 2018
Feb 25, 2019


MDCO $54.59 1.50 (2.83%)
The Medicines Co
NASDAQ: MDCO $4 Billion Mid-Cap. New 52 WEEK HIGH today. Drug Manufacturers industry. 5 Year Return 149%. 1 Year Return 97%. 2019 YTD Return 194%. Earnings in 28 days on Thu, Nov 14. (Use the Earnings tab below to add this date to your calendar.)

MDCO Profile

Market Cap 4 Billion
MDCO Description

The Medicines Company is a pharmaceutical firm that provides products to the U.S. hospital market. The company's primary commercial product, Angiomax, is an anticoagulant drug used in conjunction with aspirin for patients undergoing angioplasty. Medicines recently commercialized a new drug, Cleviprex, which is designed to control blood pressure in intensive-care settings.


Visit Website

MDCO Earnings

EPS -0.80 P/E Ratio 0.00
Previous Wed, Jul 24, 2019
Latest Thu, Nov 14, 2019 (In 29 days)

MDCO Dividend

Yield --
Ex-Date --
Pay Date --
History --

MDCO Charts

All Time High $55.95 set on Tue, Apr 11, 2017.
$16.69
1 Year
$54.68
Dec 21, 2018
Today


SEDG $83.88 0.92 (1.08%)
SolarEdge Technologies Inc
NASDAQ: SEDG $4 Billion Mid-Cap. Semiconductors industry. 5 Year Return 306%. 1 Year Return 101%. 2019 YTD Return 132%. Earnings in 21 days on Thu, Nov 7. (Use the Earnings tab below to add this date to your calendar.)

SEDG Profile

Market Cap 4 Billion
SEDG Description

SolarEdge Technologies Inc together with its subsidiaries designs develops and sells direct current (DC) optimized inverter systems for solar photovoltaic (PV) installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility‑scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers.


Visit Website

SEDG Earnings

EPS 0.69 P/E Ratio 16.00
Previous Tue, Aug 6, 2019
Latest Thu, Nov 7, 2019 (In 22 days)

SEDG Dividend

Yield --
Ex-Date --
Pay Date --
History --

SEDG Charts

All Time High $91.45 set on Tue, Sep 24, 2019.
$32.43
1 Year
$91.45
Dec 24, 2018
Sep 24, 2019


BLD $100.35 0.83 (0.83%)
TopBuild Corp
NYSE: BLD $3 Billion Mid-Cap. New ALL-TIME HIGH today. Building Materials industry. 5 Year Return 272%. 1 Year Return 101%. 2019 YTD Return 121%. Earnings in 14 days on Thu, Oct 31. (Use the Earnings tab below to add this date to your calendar.)

BLD Profile

Market Cap 3 Billion
BLD Description

TopBuild Corp is an installer and distributor of insulation products. The company operates two businesses: Truteam and Service Partners. Trueteam installs insulation products in residential and commercial building projects, primarily as a contractor to custom builders and big builders. Service Partners is a distributor of insulation and selected building products. Its main customers are contractors. Other products include gutters, afterpaint, garage doors, fireplaces, and fireproofing and stopping. TopBuild operates primarily in the United States.


Visit Website

BLD Earnings

EPS 1.53 P/E Ratio 19.11
Previous Thu, Aug 1, 2019
Latest Thu, Oct 31, 2019 (In 15 days)

BLD Dividend

Yield --
Ex-Date --
Pay Date --
History --

BLD Charts

$41.27
1 Year
$100.81
Dec 26, 2018
Today


SBGL $6.61 0.40 (6.44%)
D/B/A Sibanye-Stillwater Limited American Depositary Shares (Each representing four ordinary shares)
NYSE: SBGL $3 Billion Mid-Cap. New 52 WEEK HIGH today. Metals & Mining industry. 5 Year Return 14%. 1 Year Return 107%. 2019 YTD Return 132%.

SBGL Profile

Market Cap 3 Billion
SBGL Description

Sibanye-Stillwater is a South Africa-focused mining company. The Group currently owns and operates four underground and surface gold operations in South Africa: the Cooke, Driefontein, and Kloof operations in the West Witwatersrand region, and the Beatrix Operation in the southern Free State province. In addition to mining, the company owns and manages extraction and processing facilities at its operations, where gold-bearing ore is treated and beneficiated to produce gold dore. The gold dore is further refined at Rand Refinery into gold bars with a purity of at least 99.5% and is then sold on international markets. Sibanye holds a 33% interest in Rand Refinery, one of the largest global refiners of gold, and the largest in Africa. Rand Refinery markets gold to customers around the world.


Visit Website

SBGL Earnings

EPS 3.23 P/E Ratio 3.14
Previous --
Latest --

SBGL Dividend

Yield --
Ex-Date --
Pay Date --
History 8 Payments (Biannual)

SBGL Charts

$2.25
1 Year
$6.63
Nov 13, 2018
Today


ENPH $24.17 0.03 (0.12%)
Enphase Energy Inc
NASDAQ: ENPH $3 Billion Mid-Cap. Semiconductors industry. 5 Year Return 101%. 1 Year Return 391%. 2019 YTD Return 391%. This is Uptrending. A good sign. Earnings in 19 days on Tue, Nov 5. (Use the Earnings tab below to add this date to your calendar.)

ENPH Profile

Market Cap 3 Billion
ENPH Description

Enphase Energy Inc delivers energy management technology for the solar industry. The company designs, develops, manufactures and sells home energy solutions that connect solar generation, energy storage, and management on one intelligent platform. Its product and service portfolio consists of Enphase Microinverters, Enphase Envoy, Enphase Enlighten and Apps, Enphase Energy Services, and Enphase Storage System. The company targeting the residential and commercial markets in the United States, Canada, Mexico, the United Kingdom, France, the Benelux region, Australia, New Zealand and certain other Asian markets.


Visit Website

ENPH Earnings

EPS 0.09 P/E Ratio 0.00
Previous Tue, Jul 30, 2019
Latest Tue, Nov 5, 2019 (In 20 days)

ENPH Dividend

Yield --
Ex-Date --
Pay Date --
History --

ENPH Charts

$4.06
1 Year
$35.42
Oct 29, 2018
Aug 27, 2019


ARWR $34.51 0.16 (0.47%)
Arrowhead Pharmaceuticals Inc
NASDAQ: ARWR $3 Billion Mid-Cap. Biotech & Pharma industry. 5 Year Return 435%. 1 Year Return 156%. 2019 YTD Return 163%. Since Earnings 19%.

ARWR Profile

Market Cap 3 Billion
ARWR Description

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.


Visit Website

ARWR Earnings

EPS 0.21 P/E Ratio 0.00
Previous Wed, May 8, 2019
Latest Mon, Aug 5, 2019 (72 days ago) Price +18.51%

ARWR Dividend

Yield --
Ex-Date --
Pay Date --
History --

ARWR Charts

All Time High $36.80 set on Fri, Aug 30, 2019.
$10.41
1 Year
$36.80
Dec 24, 2018
Aug 30, 2019


NVRO $82.95 1.34 (1.59%)
Nevro Corp
NYSE: NVRO $3 Billion Mid-Cap. Medical Equipment & Devices industry. 5 Year Return 229%. 1 Year Return 50%. 2019 YTD Return 127%. Earnings in 20 days on Wed, Nov 6. (Use the Earnings tab below to add this date to your calendar.)

NVRO Profile

Market Cap 3 Billion
NVRO Description

Nevro Corp is a medical device company. Its key product is the Senza spinal cord stimulation system, a neuromodulation platform for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. Nevro generates the majority of its revenue in the United States. It also receives nearly half of its revenue from Australia, the United Kingdom, and Germany.


Visit Website

NVRO Earnings

EPS -0.91 P/E Ratio 0.00
Previous Thu, Aug 8, 2019
Latest Wed, Nov 6, 2019 (In 21 days)

NVRO Dividend

Yield --
Ex-Date --
Pay Date --
History --

NVRO Charts

$34.75
1 Year
$91.60
Dec 20, 2018
Sep 12, 2019


LSCC $19.38 0.37 (1.87%)
Lattice Semiconductor Corp
NASDAQ: LSCC $3 Billion Mid-Cap. Semiconductors industry. 5 Year Return 202%. 1 Year Return 143%. 2019 YTD Return 178%. Earnings in 12 days on Tue, Oct 29. (Use the Earnings tab below to add this date to your calendar.)

LSCC Profile

Market Cap 3 Billion
LSCC Description

Lattice Semiconductor Corp is a developer of semiconductor technology that it distributes through products, solutions, and licenses. The company reaches its customers through consumer, communications, and industrial markets. Lattice's product lines consist of programmable logic devices, video connectivity application-specific standard products, and wave devices. Product offerings enable customers in the consumer market to build technology that utilizes more computing power, higher resolution video, and reduced energy consumption. Customers in the industrial and communication market are aided with data gathering, higher bandwidth, and increased reliability for their products. Lattice's products are offered globally; however, the majority of sales are derived from customers in Asia.


Visit Website

LSCC Earnings

EPS 0.06 P/E Ratio 0.00
Previous Tue, Jul 30, 2019
Latest Tue, Oct 29, 2019 (In 13 days)

LSCC Dividend

Yield --
Ex-Date --
Pay Date --
History --

LSCC Charts

$5.38
1 Year
$21.58
Nov 20, 2018
Sep 13, 2019


RETA $166.76 8.84 (5.60%)
Reata Pharmaceuticals Inc
NASDAQ: RETA $3 Billion Mid-Cap. New ALL-TIME HIGH today. Biotech & Pharma industry. 5 Year Return 1,176%. 1 Year Return 168%. 2019 YTD Return 199%. This is Uptrending. A good sign. Earnings in 20 days on Wed, Nov 6. (Use the Earnings tab below to add this date to your calendar.)

RETA Profile

Market Cap 3 Billion
RETA Description

Reata Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing therapeutics to address serious and life-threatening disease by targeting molecular pathways.


Visit Website

RETA Earnings

EPS -1.14 P/E Ratio 0.00
Previous Thu, Aug 8, 2019
Latest Wed, Nov 6, 2019 (In 21 days)

RETA Dividend

Yield --
Ex-Date --
Pay Date --
History --

RETA Charts

All Time High $169.81 set on Wed, Oct 16, 2019.
$47.50
1 Year
$169.81
Dec 21, 2018
Today


NTRA $36.30 2.92 (7.45%)
Natera Inc
NASDAQ: NTRA $2 Billion Mid-Cap. Medical Diagnostics & Research industry. 5 Year Return 62%. 1 Year Return 70%. 2019 YTD Return 180%. Earnings in 28 days on Thu, Nov 14. (Use the Earnings tab below to add this date to your calendar.)

NTRA Profile

Market Cap 2 Billion
NTRA Description

Natera Inc is operative in the healthcare field in the United States. Its core business is to offer invasive and other means of diagnosing genetic features of a fetus. Natera's array of diagnostic services include Panorama Non-Invasive Prenatal Test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother; Anora Products of Conception (POC) test to analyze fetal chromosomes to understand the cause of miscarriage, and Non-Invasive Paternity Testing (PAT), to determine paternity by studying the fragments of fetal deoxyribonucleic acid (DNA) in a pregnant mother's blood and a blood sample from the alleged father. The Company acquires its revenue by billing an insurance carrier, a clinic or a patient for the test upon delivery of the test result.


Visit Website

NTRA Earnings

EPS -0.48 P/E Ratio 0.00
Previous Wed, Aug 7, 2019
Latest Thu, Nov 14, 2019 (In 29 days)

NTRA Dividend

Yield --
Ex-Date --
Pay Date --
History --

NTRA Charts

All Time High $39.53 set on Tue, Oct 15, 2019.
$11.08
1 Year
$39.53
Jan 8, 2019
Oct 15, 2019


ARCE $46.44 1.81 (3.75%)
Arco Platform Ltd
NASDAQ: ARCE $2 Billion Mid-Cap. Software industry. 5 Year Return 98%. 1 Year Return 104%. 2019 YTD Return 114%. This is Uptrending. A good sign. Since Earnings 25%.

ARCE Profile

Market Cap 2 Billion
ARCE Description

Arco Platform Ltd provides a complete pedagogical system with technology-enabled features to deliver educational content to private schools in Brazil. Its turnkey curriculum solutions provide educational content in both printed and digital formats delivered through its platform to improve the learning process. Products offered by the company include Core Curriculum and Supplemental Solutions. Its Core Curriculum comprises high-quality content solutions and Supplemental Solutions are comprised of additional value-added content.


Visit Website

ARCE Earnings

EPS 0.51 P/E Ratio 2007.48
Previous Tue, Nov 27, 2018
Latest Tue, May 21, 2019 (148 days ago) Price +24.97%

ARCE Dividend

Yield --
Ex-Date --
Pay Date --
History --

ARCE Charts

$17.68
1 Year
$56.74
Dec 20, 2018
Aug 19, 2019


AVP $4.13 0.01 (0.24%)
Avon Products Inc
NYSE: AVP $2 Billion Mid-Cap. Consumer Packaged Goods industry. 5 Year Return 63%. 1 Year Return 104%. 2019 YTD Return 163%. Earnings in 14 days on Thu, Oct 31. (Use the Earnings tab below to add this date to your calendar.)

AVP Profile

Market Cap 2 Billion
AVP Description

Avon Products Inc is a multilevel marketing firm which manufactures and sells beauty and related products. Avon's product mix consists of beauty (cosmetics, fragrances, and skin care), fashion (accessories and apparel), and home (home products and gifts). Generating, a majority of its revenue from Beauty. The company's geographic operating segments includes Europe, Middle East and Africa, South Latin America, North Latin America and the Asia Pacific. It generates a majority of its revenue from South Latin America followed by Europe, Middle East, and Africa.


Visit Website

AVP Earnings

EPS -0.06 P/E Ratio 0.00
Previous Thu, Aug 1, 2019
Latest Thu, Oct 31, 2019 (In 15 days)

AVP Dividend

Yield --
Ex-Date --
Pay Date --
History 122 Payments (Quarterly)

AVP Charts

$1.30
1 Year
$4.88
Dec 26, 2018
Sep 18, 2019


EIDX $35.42 0.81 (2.24%)
Eidos Therapeutics Inc
NASDAQ: EIDX $1,680 Million Small-Cap. Biotech & Pharma industry. 5 Year Return 53%. 1 Year Return 283%. 2019 YTD Return 152%. Earnings in 19 days on Tue, Nov 5. (Use the Earnings tab below to add this date to your calendar.)

EIDX Profile

Market Cap 2 Billion
EIDX Description

Eidos Therapeutics Inc is a clinical stage biopharmaceutical company focused on addressing the large and growing unmet need in diseases caused by transthyretin, or TTR, amyloidosis, or ATTR. TTR is a protein that occurs naturally in the form of a tetramer and performs multiple beneficial roles, including the transport of essential hormones and vitamins. The company's product candidate, AG10, is an orally-administered small molecule designed to potently stabilize tetrameric TTR.


Visit Website

EIDX Earnings

EPS -0.39 P/E Ratio 0.00
Previous Thu, Aug 1, 2019
Latest Tue, Nov 5, 2019 (In 20 days)

EIDX Dividend

Yield --
Ex-Date --
Pay Date --
History --

EIDX Charts

All Time High $49.72 set on Thu, Sep 19, 2019.
$9.03
1 Year
$49.72
Oct 17, 2018
Sep 19, 2019


EGO $7.39 0.16 (2.21%)
Eldorado Gold Corporation Ordinary Shares
NYSE: EGO $1,380 Million Small-Cap. Metals & Mining industry. 5 Year Return 79%. 1 Year Return 62%. 2019 YTD Return 133%. Earnings in 14 days on Thu, Oct 31. (Use the Earnings tab below to add this date to your calendar.)

EGO Profile

Market Cap 1 Billion
EGO Description

Eldorado Gold is a midtier gold producer with mines in Turkey, Greece, and Brazil that produced 349,147 ounces of gold at total cash cost of $650 per ounce in 2018. Eldorado has roughly 17 million ounces of proven and probable reserves and is based in Vancouver, British Columbia.


Visit Website

EGO Earnings

EPS 0.08 P/E Ratio 0.00
Previous Thu, Aug 1, 2019
Latest Thu, Oct 31, 2019 (In 15 days)

EGO Dividend

Yield --
Ex-Date --
Pay Date --
History 13 Payments (Biannual)

EGO Charts

$2.52
1 Year
$10.09
Jan 22, 2019
Sep 4, 2019


RARX $46.66 0.34 (0.72%)
Ra Pharmaceuticals Inc
NASDAQ: RARX $1,200 Million Small-Cap. Biotech & Pharma industry. 5 Year Return 259%. 1 Year Return 184%. 2019 YTD Return 113%. This is Uptrending. A good sign. Earnings in 20 days on Wed, Nov 6. (Use the Earnings tab below to add this date to your calendar.)

RARX Profile

Market Cap 1 Billion
RARX Description

Ra Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It discovers and develops therapeutics for the treatment of diseases caused by excessive or uncontrolled activation of the complement system. Its lead product candidate is RA101495, an injection into the tissue under the skin for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), as well as for the treatment of other debilitating complement-mediated diseases, including refractory generalized myasthenia gravis and lupus nephritis. Geographically business of the firm can be seen amplifying in the United States, Europe and even at international level.


Visit Website

RARX Earnings

EPS -0.52 P/E Ratio 0.00
Previous Wed, Aug 7, 2019
Latest Wed, Nov 6, 2019 (In 21 days)

RARX Dividend

Yield --
Ex-Date --
Pay Date --
History --

RARX Charts

All Time High $47.08 set on Tue, Oct 15, 2019.
$11.27
1 Year
$47.08
Nov 13, 2018
Oct 15, 2019


DBD $9.37 0.05 (0.53%)
Diebold Nixdorf Inc
NYSE: DBD $1,030 Million Small-Cap. Software industry. 5 Year Return 74%. 1 Year Return 131%. 2019 YTD Return 247%. Earnings in 13 days on Wed, Oct 30. (Use the Earnings tab below to add this date to your calendar.)

DBD Profile

Market Cap 1 Billion
DBD Description

Diebold Nixdorf Inc is engaged in providing software and hardware services for financial and retail industries. The customer segments of the company are banking which offers integrated solutions for financial institutions and retail that offers solutions, software, and services which improves the checkout process for retailers.


Visit Website

DBD Earnings

EPS -0.66 P/E Ratio 0.00
Previous Thu, Jul 25, 2019
Latest Wed, Oct 30, 2019 (In 14 days)

DBD Dividend

Yield --
Ex-Date --
Pay Date --
History 134 Payments (Quarterly)

DBD Charts

$2.41
1 Year
$14.66
Dec 24, 2018
Jul 31, 2019




Symbol Price Day Δ YTD Δ
ACAD $39.90 -0.65% 139.64%
ARCE $46.44 -3.75% 113.91%
ARWR $34.51 0.47% 163.03%
AVP $4.13 -0.24% 163.06%
BLD $100.35 0.83% 121.33%
COUP $140.31 -9.30% 124.60%
CVNA $76.55 -1.64% 137.29%
DBD $9.37 -0.53% 247.04%
EGO $7.39 2.21% 133.12%
EIDX $35.42 -2.24% 152.46%
ENPH $24.17 0.12% 391.26%
LSCC $19.38 -1.87% 178.45%
MDCO $54.59 2.83% 193.97%
NTRA $36.30 -7.45% 180.31%
NVCR $76.14 -3.24% 132.70%
NVRO $82.95 -1.59% 126.95%
ONCE $100.12 1.05% 156.00%
RARX $46.66 -0.72% 113.06%
RETA $166.76 5.60% 199.23%
ROKU $132.50 -0.24% 307.44%
SBGL $6.61 6.44% 131.93%
SE $28.09 -0.67% 154.21%
SEDG $83.88 -1.08% 132.03%
SHOP $323.64 -6.48% 135.20%
SNAP $13.67 -2.98% 136.10%

Channels

Symbol Surfing

How can we make Symbol Surfing better?

info@symbolsurfing.com







©2019 Symbol Surfing All Rights Reserved.

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Cookies Policy | Terms Of Service | Privacy Policy